"We are a non-profit kidney health organization providing chronic kidney disease education, dialysis services, and transplant support services."

During the past decade, DCI Dialysis Unit-Somerville conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "DCI Dialysis Unit-Somerville" are "Atherosclerosis" (2 trials), "Cardiovascular Disease" (2 trials), "Dialysis" (2 trials), "Inflammation" (2 trials) and "Hyperphosphatemia" (1 trials). Many other conditions were trialed in "DCI Dialysis Unit-Somerville" in a lesser frequency.

Most popular intervention types in "DCI Dialysis Unit-Somerville" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Extended Release Nicotinic Acid (Niaspan)" (1 trials) and "Sevelamer Carbonate (Renvela)" (1 trials). Other intervention names were less common.

The vast majority of trials in "DCI Dialysis Unit-Somerville" are 2 trials for "All" genders.

Currently, there are NaN active trials in "DCI Dialysis Unit-Somerville". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in DCI Dialysis Unit-Somerville, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in DCI Dialysis Unit-Somerville, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".